Central American Regulation for Drug Products (LATAM)

February 2, 2021 | 03:00 PM CET


Summary

**For more information, please see PharmaLex Privacy Policy and Veeva Privacy Policy

If you do not wish to receive any communication from us, you may unsubscribe at any time.

In October 1993, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua and Panama signed the Protocol to the General Agreement of Central American Economic Integration, better known as Guatemala Protocol; such Protocol has as main objectives, among others, to reach an economic union, strengthening the finance system of the region and create a Central American Integration System supported in an Institutional and Legal Order. 

This Central American System leads to the creation of the Council of Ministers of Economic Integration (COMIECO) composed by the Ministries of Economy of the country members, these Ministries were responsible to develop the Central American Technical Regulation (RTCA) that rule the Pharmaceutical Industry in the Region.

The RTCA is for the pharmaceutical industry covers several topics from the technical point of view like Analytical Method Validation, Good Manufacturing Practices, Labelling of Pharmaceutical Products, Quality Assurance, Stability Studies and Requirements for Marketing Authorizations. These regulations give clarity to the Pharmaceutical Companies regarding the expectations of the region for technical dossiers and help companies to accelerate their expansion projects in Central America.


Why Attend

  •  Introduce the participants to the Economic Integration in Central America
  •  Content of Main Central American Regulations for Pharmaceutical Products
  •  Submission process in the Region: advantages and disadvantages 
speakers

Inspirational speakers from across the globe.


Diego Zavala

Regional Senior Manager LATAM, PharmaLex

Diego is a pharmacist with over 10 years of experience in Regulatory Affairs with focus on Latin American Region. In 2015, he obtained his master’s degree on Business Administration from the National Autonomous University of Mexico. He has worked in Big Pharma as same as Medium size companies in Mexico and Germany managing global projects related to changes in manufacturing sites as well as creating expansion strategies in the region. Currently, Diego is based in Germany working as Regional Senior Manager supporting companies who aim to increase their presence Latin America, MENA and African Markets.